エーザイ株式会社 — Tokyo Stock Exchange 4523, Pharmaceutical. Supply-chain directory entry built from public EDINET filings, including relationships the company disclosed in its own annual securities report.
COMPANY NAME (JP)
エーザイ株式会社
TICKER
TSE 4523
EDINET CODE
E00939
CORPORATE NUMBER
6010001000001
INDUSTRY
Pharmaceutical (医薬品)
HEAD OFFICE
文京区小石川４丁目６番１０号
DISCLOSED FOOTPRINT
13 sites · 49 subsidiaries
Disclosed major customers
Counterparties Eisai Co., Ltd. named in its own annual securities report. A company named here has Eisai Co., Ltd. in its supply base.
The filing states a human-rights policy and describes human-rights due diligence: “当社グループでは、2019年3月に「ENW人権方針」を策定しました。国際人権規範に基づく対応は、全社会議体である「ビジネスと人権委員会」が担っています。同委員会にて審議・報告する人権デューデリジェンスにおいて、2025年度は、2024年度に子会社、工場・研究所、一次取引先を対象として実施した人権リスクの高い業種や国・地域を特定するためのアンケート調査結果に基づき、人権リスクの高い取引先や国・地域へのリスク低減施策を実行しました。2026年度以降も人権に負の影響を及ぼす可能性のあるリスクの回避・低”
Screening Eisai Co., Ltd. or mapping suppliers like them? Check any company against sanctions and forced-labor lists, free.Free sanctions check →
Work at Eisai Co., Ltd.? Claim this page to review the data your customers see.
Get sanctions & UFLPA list updates
A short note when the lists change in ways that matter for supply-chain screening. No noise.
Sources: EDINET code list (Financial Services Agency) and the company’s own annual securities report (有価証券報告書) retrieved via EDINET. Disclosed relationships are quoted from the filing and carry its EDINET accession number; extraction is automated and conservative — anything the filing does not state is left out. Tieron does not certify, audit or endorse the company, and this page contains no Tieron risk assessment. Report an issue with this page — corrections referencing the accession number shown above are fastest to verify.